Cargando…

Myeloid leukemia: are we getting better?()

Detalles Bibliográficos
Autor principal:	Hamerschlak, Nelson
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Hematologia e Hemoterapia 2015
Materias:	Scientific Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318839/ https://www.ncbi.nlm.nih.gov/pubmed/25638758 http://dx.doi.org/10.1016/j.bjhh.2014.11.006

Ejemplares similares

Let us think about lymphocyte counts!
por: Hamerschlak, Nelson
Publicado: (2012)

Diffuse large B cell gastric lymphoma a rare disease: the effort to obtain scientific data in a multicenter, multinational retrospective trial()
por: Hamerschlak, Nelson
Publicado: (2016)

Changing COVID-19 outcomes in patients with rheumatic disease—are we really getting better at this?
por: Gianfrancesco, Milena A, et al.
Publicado: (2021)

Genetic polymorphisms, chronic lymphocytic leukemia, and the future: are we there yet?
por: Caimi, Paolo F., et al.
Publicado: (2014)

The expression of the CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia
por: Rego, Eduardo Magalhães
Publicado: (2011)

Successful treatment of chronic myeloid leukemia with tyrosine kinase inhibitors goes beyond access to drugs
por: Conchon, Monika
Publicado: (2013)

BCR-ABL1 level monitoring in chronic myeloid leukemia by real time polymerase chain reaction in Brazil – not so real()
por: Pagnano, Katia Borgia Barbosa
Publicado: (2017)

Comment on: Determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance
por: Simpson, David C
Publicado: (2013)

Scientific comment on: “Analysis of imatinib adherence in chronic myeloid leukemia: a retrospective study in a referral hospital in the Brazilian Amazon”. Who likes to take medicine forever?()
por: Bendit, Israel
Publicado: (2019)

We need to talk more about transfusion-transmitted malaria in Plasmodium vivax endemic areas()
por: Lacerda, Marcus Vinícius Guimarães, et al.
Publicado: (2014)

Secondary myeloid neoplasias: an emerging group of diseases
por: Hernández-Rivas, Jesús M
Publicado: (2011)

How can we get sober from the influence of the alcohol industry?
por: Monteiro, Maristela G, et al.
Publicado: (2022)

Metaphase cytogenetics and single nucleotide polymorphism arrays in myeloid malignancies()
por: da Silva, Fernanda Borges, et al.
Publicado: (2015)

Hodgkin's lymphoma in developing countries: can we go further?()
por: Gaiolla, Rafael Dezen
Publicado: (2017)

Pyruvate kinase deficiency: novel mutations and a better understanding of the genotype-to-phenotype correlation in Brazilian patients()
por: Cançado, Rodolfo Delfini
Publicado: (2018)

Compliance and adherence of patients in the treatment of acute lymphoblastic leukemia
por: Barr, Ronald Duncan
Publicado: (2011)

Pregnancy in sickle cell disease – do we know what to expect?()
por: Fertrin, Kleber Yotsumoto
Publicado: (2014)

Compound heterozygosity for hemoglobin S and D: what do we need to know?()
por: Bonini-Domingos, Claudia Regina
Publicado: (2016)

National neonatal screening program for hemoglobinopathies: how far have we advanced?()
por: da Fonseca, Silvana Fahel
Publicado: (2014)

Involvement of the cerebrospinal fluid cells in children with acute lymphoblastic leukemia: prognostic implications
por: Scrideli, Carlos Alberto
Publicado: (2012)

ABO isohemagglutinin titration or hemolysin test: what should we do to reduce the risk of passive hemolysis?()
por: Castilho, Lilian
Publicado: (2015)

BCR-ABL rearrangement and HLA antigens: a possible link to leukemia pathogenesis and immunotherapy
por: Giunta, Marina, et al.
Publicado: (2012)

The treatment of acute lymphoblastic leukemia has come a long way but the best is yet to come
por: Chauffaille, Maria de Lourdes Lopes Ferrari
Publicado: (2013)

Targeting adhesion to the vascular niche to improve therapy for acute myeloid leukemia
por: Haltalli, Myriam L. R., et al.
Publicado: (2020)

Qualitative polymerase chain reaction versus quantitative polymerase chain reaction for the detection of minimal residual disease in children with acute lymphoblastic leukemia()
por: Scrideli, Carlos Alberto, et al.
Publicado: (2015)

Conditioning regimen using busulfan plus melphalan in hematopoietic stem cell transplantation: can this conditioning regimen be used in autologous or allogeneic transplantation for acute leukemia?
por: Lemoli, Roberto M., et al.
Publicado: (2011)

How We Manage Invasive Fungal Disease in Acute Myeloid Leukemia Patients with Glucose 6 Dehydrogenase Deficiency
por: Sanna, Marco, et al.
Publicado: (2017)

Monoclonal B-cell lymphocytosis()
por: Biasoli, Irene, et al.
Publicado: (2015)

New agents in relapsed/refractory Hodgkin's lymphoma()
por: Biasoli, Irene, et al.
Publicado: (2017)

Getting the upper hand in ALS
por: Svendsen, Clive N.
Publicado: (2022)

WANTED: Better neuroblastoma biomarkers and better stratification
por: London, Wendy B.
Publicado: (2022)

Let's get our priorities straight
por: Petsko, Gregory A
Publicado: (2006)

Getting political: fighting for global health
por: Erikson, Susan L
Publicado: (2008)

Myeloid Sarcoma Presenting as Brain Tumor in Pediatric Acute Myeloid Leukemia Case
por: Solgun, Hüseyin Avni, et al.
Publicado: (2023)

Do we need “more research” or better implementation through knowledge brokering?
por: Hering, Janet G.
Publicado: (2015)

Open questions: how to get developmental biology into shape?
por: Saunders, Timothy E., et al.
Publicado: (2019)

Machine learning for psychiatry: getting doctors at the black box?
por: Hedderich, Dennis M., et al.
Publicado: (2020)

Can precision medicine get us through menopause?
por: Vieira-Potter, Victoria J.
Publicado: (2022)

When bigger is better
por: Petsko, Gregory A
Publicado: (2010)

Comment on Association of FLT3-internal duplication length with overall survival in acute myeloid leukemia: a systematic review and meta-analysis
por: Tong, Wing H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dd3hjt42s6o5uv9oph3o1852kj